GPT Healthcare Q3 FY26: revenue up 18% but PAT drops 24% on margin pressure

EBITDA margin compressionResults View source PDF Explain this filing

GPTHEALTH · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-0.5%Reaction day

₹128.15

prior close

₹131.00

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+3.7%-4.2% vs market

Hospital peers, median of 22sector+1.3%-1.8% vs sector

On the reaction day the stock moved 4.2 pts less than Nifty Microcap 250 and 1.8 pts less than its Hospital peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-3.9

10m

-4.0

15m

-3.6

30m

-4.0

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-0.5+3.7-4.2+1.3-1.8

Next day

+1.0+5.1-4.1+2.0-1.1

-0.8+4.0-4.8+0.9-1.7

+0.7+3.2-2.5+0.6+0.1

+0.4+5.9-5.5+3.5-3.1

+1.4+6.9-5.6+4.7-3.4

+0.7+5.9-5.2+5.7-5.0

15d

-4.4+2.1-6.5+5.0-9.4

-5.7-3.5-2.3+1.1-6.9

-2.3-4.2+1.9-0.6-1.7

+10.2+10.9-0.7+5.6+4.6

UpDownMarket · Nifty Microcap 250Sector · Hospital peers, median of 22Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

GPT Healthcare's Q3 FY26 revenue rose 17.6% YoY to 120.16 crore, but PAT fell 23.5% to 9.37 crore. For 9M FY26, revenue grew 13.2% to 346.18 crore while PAT dropped 25.3% to 27.65 crore. Other expenses and depreciation rose sharply, driving significant margin compression. Auditor S.R. Batliboi gave an unmodified review report.

Likely market impact

Rising costs squeezed margins even as topline grew. Watch whether cost pressures ease in Q4 or whether margin compression is structural for the stock.